A Genetic Polymorphism in CTLA-4 Is Associated with Overall Survival in Sunitinib-Treated Patients with Clear Cell Metastatic Renal Cell Carcinoma

Author(s):
Liu, X.Y.; Swen, J.J.; Diekstra, M.H.M.; ; Castellano, D.; Gelderblom, H.; Mathijssen, R.H.J.; Vermeulen, S.H.; Oosterwijk, E.; Junker, K.; Roessler, M.; Alexiusdottir, K.; Sverrisdottir, A.; Radu, M.T.; Ambert, V.; Eisen, T.; Warren, A.; Rodriguez-Antona, C.; Garcia-Donas, J.; Bohringer, S.; Koudijs, K.K.M.; Kiemeney, L.A.L.M.; Rini, B.I.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-05-15
Language
English
Is part of
Clinical Cancer Research (2018), Vol. 24, no. 10, p. 2350-2356
hdl
1887/95569
doi
10.1158/1078-0432.CCR-17-2815